NGM Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NGM and buy or sell other stocks, options, and ETFs commission-free!About NGM
NGM Biopharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel biologic drug candidates. Its programs include NGM707 and pembrolizumab for treating metastatic solid tumors, Aldafermin for primary sclerosing cholangitis, and NGM120 for hyperemesis gravidarum.
CEODavid J. Woodhouse, PhD, MBA
CEODavid J. Woodhouse, PhD, MBA
Employees138
Employees138
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2007
Founded2007
Employees138
Employees138
NGM Key Statistics
Market cap127.68M
Market cap127.68M
Price-Earnings ratio-0.89
Price-Earnings ratio-0.89
Dividend yield—
Dividend yield—
Average volume536.23K
Average volume536.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.69
52 Week high$4.69
52 Week low$0.6002
52 Week low$0.6002